U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354035) titled 'The Coronary Sinus Balloon Pump in STEMI' on Jan. 05.
Brief Summary: This study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate the safety and efficacy of the coronary sinus balloon pump (manufactured by Shanghai MicroPort Rotapace Medical Technology Co., Ltd.) as an adjunctive therapy during percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI). As a pivotal study, it aims to support the product registration application to the National Medical Products Administration (NMPA).
Study Start Date: Feb. 12
Study Type: INTERVENTIONAL
C...